MetLife Inc. has recently seen a notable shift in its shareholder structure, as reported in a Schedule 13G/A filing. The filing, submitted by Dodge & Cox, reveals that the investment firm now holds 5.3% of MetLife's common stock, translating to approximately 33.6 million shares. This development is significant as it indicates a strong interest from a prominent investment firm in the life insurance sector.

MetLife Inc., an established player in the life insurance industry, is listed on the New York Stock Exchange under the ticker symbols MET, MET-PA, MET-PE, and MET-PF. The company, classified under SIC 6311, provides a range of insurance products and services. The recent filing, dated November 12, 2026, is part of a series of disclosures that highlight the ongoing activities and interests of major stakeholders in the company.

The Schedule 13G/A filing indicates that Dodge & Cox has beneficial ownership of 33,642,167 shares of MetLife, with sole voting power over 32,079,592 shares. The filing states, "The clients of Dodge & Cox, including investment companies registered under the Investment Company Act of 1940 and other managed accounts, have the right to receive or power to direct the receipt of dividends from, and the proceeds from the sale of, MetLife, Inc." This underscores the firm's significant influence over a portion of MetLife's equity.

This increase in ownership may affect various stakeholders, including MetLife's management, existing shareholders, and competitors in the life insurance market. As Dodge & Cox solidifies its position, it could influence strategic decisions within MetLife, potentially leading to shifts in company policies or direction.

Looking ahead, the filing does not specify what actions may follow this change in ownership. However, it does reflect a growing trend of investment firms taking significant stakes in established companies within the life insurance sector, suggesting a competitive landscape that may continue to evolve.